CEACAM1 has been described as a tumor suppressor being down-regulated in several tumor entities including colon carcinoma, hepatocellular carcinoma, a proportion of breast cancers, bladder cancer, and PCa (24–26). This evidence concerns the gene CEACAM1 and posterior cortical atrophy.